MYG 7-Year with MVA review

Yes, for the right buyer. If you want a guaranteed fixed rate locked in for seven years and you have a retirement time horizon that makes a seven-year commitment reasonable, this is a solid product from a well-capitalized carrier. It is less appealing if you have any material chance of needing the money within the surrender period, or if you are in one of the states where the MVA does not apply and you are comparing it against plain fixed annuities on rate alone.

The straightforward reason to buy this product is certainty. The multi-year fixed strategy guarantees the rate for the full seven-year term on initial premium — you know exactly what you are getting. In an environment where CD and fixed annuity rates move around at renewal, that kind of lock-in has genuine value for someone planning a retirement income timeline. The RMD-friendly free withdrawal provision is also meaningful for qualified money, because required distributions will not trigger surrender charges even if they exceed the 10% annual free amount.

I think this product is best for someone in their 50s or early 60s who is positioning a portion of retirement savings into a guaranteed-growth vehicle and does not need income or index-linked upside from this particular bucket. It works well for qualified accounts because of the RMD treatment. The $5,000 minimum also makes it accessible for smaller lump sums. It is not a fit for someone who might need the full principal before the seven years are up, for someone who wants participation in index gains, or for someone whose primary goal is lifetime income.

You are buying an insurance contract that promises a fixed interest rate for seven years. There is no index exposure, no market participation, and no optionality — just a guaranteed rate on a protected principal. The tax-deferred growth is the main financial advantage over a taxable CD, and the death benefit plus waivers provide limited but real protection against life events. What you are giving up is access: money committed here is essentially illiquid above the 10% annual free withdrawal until the surrender period ends or a waiver condition is met.

The multi-year fixed strategy is the product's centerpiece. Athene guarantees the credited rate for the full seven-year surrender period on the initial premium — you do not face annual repricing risk the way you would with a shorter-term annuity that renews. The rate bands by deposit size: contracts under $100,000 receive one rate, contracts at $100,000 or more receive a higher rate. As of the current Wink data (April 2026), those rates were 5.00% and 5.30% respectively — but rates are a snapshot, not a contract guarantee for future buyers.

Additional premiums after issue go into a 1-Year Fixed Strategy rather than the multi-year strategy. That means contributions made after the initial deposit are on a different renewal cycle and do not lock in the original rate. Buyers who intend to make ongoing contributions should factor this into how they evaluate the product.

The confinement and terminal illness waivers are the secondary feature worth understanding. If you are confined to a qualified care facility for 60 or more consecutive days after the first contract year, Athene will allow a full surrender without the usual charges or MVA — giving you access to 100% of accumulated value when a health crisis would otherwise force a costly exit. The terminal illness waiver works similarly for diagnoses with less than a year to live, also available after the first anniversary. These provisions do not make the product a long-term care solution, but they do remove one of the more painful failure modes of a long surrender product: being locked in when a health event demands cash. Note that the confinement waiver does not apply in California or Massachusetts, and the terminal illness waiver does not apply in California.

The free-withdrawal provision allows 10% of accumulated value each year starting in contract year one. RMDs are also included in this provision — if your required minimum distribution exceeds the 10% free amount, Athene will honor it without triggering charges. That is an important feature for IRA and qualified plan money.

Beyond the free amount, the surrender schedule is meaningful: 8% in years one and two, stepping down to 3% in year seven. Athene also applies a Market Value Adjustment — MVA — to withdrawals subject to surrender charges in most states. The MVA adjusts the surrender cost based on interest rate movements since the contract was issued. If rates have risen, the MVA increases your exit cost; if rates have fallen, it decreases it. This means the actual cost of exiting early can be higher or lower than the schedule alone implies, depending on the rate environment. In twelve states (AK, CT, HI, IN, MN, MO, NJ, OH, OR, PA, SC, WA), the MVA does not apply. Buyers in those states are working with a standard surrender schedule and no rate-adjustment risk.

There is no base contract fee and no rider fee — the product does not charge an annual expense against accumulated value, which is standard for MYGAs. The cost here is entirely structural: the spread between what Athene earns on the underlying portfolio and what it credits to the contract, and the surrender charges if you exit early.

The main tradeoff is the MVA. Buyers in MVA states are taking on an implicit interest-rate risk they would not have with a plain fixed annuity. In a rising-rate environment, an early surrender could result in a meaningful shortfall relative to the stated surrender charge percentage. That is not a hidden fee — it is a disclosed contract feature — but it is something to price in before committing, especially for buyers who are uncertain about their seven-year timeline.

Legal Entity: Athene Annuity and Life Company

Parent: Apollo Global Management

A.M. Best Rating: A+

Athene is a large, well-capitalized annuity carrier with A+ financial strength from A.M. Best. It is one of the major players in the fixed annuity and MYGA market, and this product reflects a mainstream guaranteed-rate design rather than a niche offering. Apollo's ownership gives Athene a robust investment management platform, which has historically supported competitive crediting rates.